Table 5.
Relationship between the therapeutic response and the general characteristics of patients.
| Parameters | Univariate analysis Complete response | P |
|---|---|---|
| Age (years) | ||
| <60 | 22/52 (42) | 0.552 |
| ≥60 | 5/11 (45) | |
| Sex | ||
| Male | 18/42 (43) | 0.787 |
| Female | 9/21 (43) | |
| Socioeconomic standing | ||
| Low | 7/32 (22) | 0.001 |
| Medium | 13/22 (59) | |
| High | 7/9 (77) | |
| IPI | ||
| Low risk (0, 1) | 5/6 (83) | <0.0001 |
| Intermediate risk (2) | 13/16 (81) | |
| High risk (≥3) | 9/41 (22) | |
| Site | ||
| Nodal | 18/37 (49) | 0.395 |
| Extranodal | 9/26 (35) | |
| Consultation period (month) | ||
| <3 | 10/15 (67) | 0.06 |
| 3–6 | 10/26 (38) | |
| >6 | 7/22 (32) | |
| Stage of Ann Arbor | ||
| I, II | 16/18 (89) | <0.0001 |
| III, IV | 11/45 (24) | |
| Clinical B symptoms | ||
| No | 8/16 (50) | 0.706 |
| Yes | 19/47 (40) | |
| Biological b symptoms | ||
| No | 17/26 (65) | 0.01 |
| Yes | 5/37 (13) |